What is the difference between in vitro and in vivo cardiac safety testing?

In vitro testing is conducted outside a living organism, allowing for controlled experimentation on isolated cells or tissues. In contrast, in vivo testing involves live animals and gives insights into the overall physiological effects of drugs but can be more costly and complex.

How does cardiac safety monitoring in vitro impact drug development timelines?

By identifying potential cardiac safety issues early in R&D processes, in vitro monitoring can prevent costly late-stage failures, helping companies bring therapies to market more efficiently.

Are in vitro methods sufficient for cardiac safety assessment?

While in vitro methods are invaluable for initial screening and understanding mechanisms, they should complement in vivo studies for a comprehensive safety evaluation prior to clinical trials.